|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03681 SINOMAB BIO-B
Nominal 
1.220 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 1,365 | -- | 0 | 25,913 | 0 | 0 |
| Cost of Sales | (943) | -- | -- | -- | -- | -- |
| Gross Profit | 422 | -- | -- | -- | -- | -- |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (5,396) | (4,289) | (747) | 0 | |
| Profit / (Loss) before Taxation | (243,111) | -14.445% | (284,158) | (288,194) | (122,600) | (276,282) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (243,111) | -14.445% | (284,158) | (288,194) | (122,600) | (276,282) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 408 | -- | (4,620) | (10,910) | (14,930) | (655) |
| Depreciation & Amortisation | 36,064 | 28.648% | 28,033 | 20,655 | 10,673 | 8,489 |
| Directors' Emoluments | 6,238 | -0.637% | 6,278 | 69,907 | 6,880 | 3,129 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -24.000 | -17.241% | -29.000 | -29.000 | -12.000 | -33.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.131) | -- | (0.303) | (0.148) | (0.140) | (0.266) |
| NBV per share ($) | 0.286 | -- | 0.492 | 0.676 | 0.981 | 1.125 |
| Remarks: | Real time quote last updated: 11/11/2024 09:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -90,622,000 |
| %Change | -32.420% |
| EPS / (LPS) | RMB -0.080 |
| NBV Per Share (¥) | RMB 0.254 |